NMS Group
Company
NMS Group develops one asset, in phase 1 (NMS-03597812 in multiple myeloma). Mostly small molecule.
- 1
- Asset
- Furthest stage
- Phase 1
- 1
- Trial
- 0
- Signals
Pipeline
1Phase 1, Small molecule, multiple myeloma
Full company profiles: pipeline, trials, funding and people.
Subsidiaries
11 asset, 1 trial
In the full profile
- Evidence behind the mechanisms1
- Trials1
- Similar companies6